Skip to main navigation Skip to search Skip to main content

Phase I clinical trial of safety of L-serine for ALS patients

  • Todd D. Levine
  • , Robert G. Miller
  • , Walter G. Bradley
  • , Dan H. Moore
  • , David S. Saperstein
  • , Lynne E. Flynn
  • , Jonathan S. Katz
  • , Dallas A. Forshew
  • , James S. Metcalf
  • , Sandra A. Banack
  • , Paul A. Cox
  • Phoenix Neurological Associates
  • California Pacific Medical Center
  • University of Miami Leonard M. Miller School of Medicine
  • Brain Chemistry Labs
  • Institute for Ethnomedicine

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)107-111
Number of pages5
JournalAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Volume18
Issue number1-2
DOIs
StatePublished - Jan 2 2017
Externally publishedYes

ASJC Scopus Subject Areas

  • Neurology
  • Clinical Neurology

Keywords

  • ALS
  • BMAA
  • L-serine
  • phase I
  • therapeutic trial

Cite this